Avid Bioservices, Inc. (CDMO)

Avid Bioservices Balance Sheet

Financials in millions USD. Fiscal year is May - April.

Year	2024	2023	2022	2021	2020
Cash & Equivalents	38.11	38.89	126.52	170.27	36.61
Cash & Cash Equivalents	38.11	38.89	126.52	170.27	36.61
Cash Growth	-2.02%	-69.26%	-25.69%	365.05%	9.29%
Receivables	16.64	18.3	20.55	18.84	8.61
Inventory	30.38	43.91	26.06	11.87	10.88
Other Current Assets	18.88	11.35	6.9	6.83	3.66
Total Current Assets	104	112.45	180.02	207.8	59.76
Property, Plant & Equipment	227.67	220.54	129.76	56.15	47.21
Other Long-Term Assets	4.88	118.57	120.06	1.56	0.65
Total Long-Term Assets	232.56	339.12	249.82	57.71	47.86
Total Assets	336.56	451.57	429.84	265.51	107.62
Accounts Payable	20.67	24.59	9.5	9.26	5.93
Deferred Revenue	39.89	37.35	53.8	50.77	29.12
Current Debt	1.35	141.98	2.97	1.36	5.61
Other Current Liabilities	8.66	11.22	9.49	9.56	3.83
Total Current Liabilities	70.57	215.15	75.76	70.94	44.48
Long-Term Debt	205.03	47.25	179.56	116.84	21.24
Other Long-Term Liabilities	0.07	0	0	0	0
Total Long-Term Liabilities	205.1	47.25	179.56	116.84	21.24
Total Liabilities	275.67	262.4	255.32	187.77	65.72
Total Debt	206.38	189.23	182.53	118.19	26.85
Debt Growth	9.06%	3.68%	54.43%	340.18%	-
Retained Earnings	-571.87	-431.12	-431.38	-559.86	-571.07
Shareholders' Equity	60.89	189.17	174.53	77.74	41.9
Net Cash / Debt	-168.28	-150.34	-56.01	52.07	9.76
Net Cash / Debt Growth	-	-	-	433.47%	-70.86%
Net Cash Per Share	-2.66	-2.36	-0.79	0.88	0.17
Working Capital	33.44	-102.7	104.26	136.87	15.28
Book Value Per Share	0.96	3.04	2.84	1.33	0.74

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).